Form 8-K ORTHOPEDIATRICS CORP For: Sep 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles up 2% after Trump rejects return to Iran ceasefire deal terms
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Ovintiv adds 41,000 acres in Permian and Montney deals
- Rubrik (RBRK) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY27 EPS Guidance
Needham Reiterates Buy Rating on OrthoPediatrics Corp. (KIDS)
September 13, 2024 5:15 AM EDTNeedham analyst Mike Matson reiterated a Buy rating and $42.00 price target on OrthoPediatrics Corp. (NASDAQ: KIDS).
The analyst comments "At KIDS' 9/12/24 investor day, management provided updates on growth strategies for Scoliosis and Trauma & Deformity (T&D), announced the launch of the Enabling... More
OrthoPediatrics Corp. (KIDS) PT Raised to $34 at Truist Securities
September 13, 2024 5:13 AM EDTTruist Securities analyst Kaila Krum raised the price target on OrthoPediatrics Corp. (NASDAQ: KIDS) to $34.00 (from $30.00) while maintaining a Hold rating.
The analyst comments "KIDS' I-Day emphasized a diversifying set of growth drivers---new prod launches, addt'l target markets, and a scaling sales... More
